text:
Arab-Israeli relations timeline
By CickNipperton441
Israel declared independence. Egypt, Jordan, Lebonan, and Iraq attacked Israel. Israel ended up gaining land. Egypt had gained the Gaza Strip, and Jordan gained the West Bank and East Jeruselum. Hundreds of Palestinians and Jews became refugees.
Six Day War/1967 War
Egypt blockaded Israel. Egypt, Jordan, Syria, and Iraq moved troops to Israel's borders and made threatening statements. Israel launched a preemptive strike.
Settlement Construction Begins
1967 June 6th - Israel began to construct illegal Jewish-Only communities in its occupied territories. The tension between Israel and the Palestinians rose as a result, and there were continued unfair and illegal acts.
Attrition battles
1967-1970 - Was launched by Egypt, and was meant to wear down Israel. It was also meant to gain back land lost during the Six Day war. Egypt used technology to give Israel heavy losses. The war reached an inconclusive end, with no obvious victor. The war was nicknamed the inconclusive War.
The October war
October 6th-24th - Egypt and Syria attacked Israel to start the war, and The U.S. intervene, helping Israel. Eventually, the fighting turned to the Arabs. Israel won the war, and the U.S. had lost much. The war brought the U.S. closer to nuclear war with the U.S.S.R. An oil embargo was also put on the U.S. by the Arabs.
Egypt and Israel sign a peace agreement
1979 March 26th - Egypt and Israel make peace, which ended violence between the different nations. As a result of the agreement, all tensions and violence were ended for a time.
1982 Lebanon War
June-Sept. - It was called Operation Peace. At the time before, Lebanon was a safe haven for terrorists. From here, the PLO staged 270 terror attacks on Israel during a cease-fire. The war was ended after a terror group led by Abu Nidal attempted to assassinate an Israeli ambassador to Great Britain. As a result of the attempt, Israeli troops surrounded the terror group, and they surrendered.
First Intifada
December,1987-1993 - Was an uprising against the Israeli occupation of Palestinian territory. Many Palestinians, mostly children, were killed, which attracted the attention of the world.
Oslo Accords
Signed in sept 13,1993 - Was the start of the peace process, and took 100 years to be signed fully. Also considered the turning point of the conflict, although Jordan still disagreed with it. As a result, fighting erupted again.
Israel and Jordan sign Peace Treaty
October 26,1994 - Israel and Jordan make peace, and Jordan is given back its land. This allows Israel and Jordan to exchange goods, communicate together, and work together in scientific fields.
Camp David Summit
July 11-24, 2000 - Was presidential retreat, to try to create peace between Israel and the Arab states. It was cut short by a wave of palestinian attacks. Instead of peace, a settlement offer was put into place. The offer was refused, and the fighting intensified, ending the summit
Second Intifada
2000-ongoing, started sept - Was second Palestinian uprising against Israel's occupation. At least 973 Palestinians died, most very young
proposition of Arab peace initiative
March - Was a ten sentence proposal to end the Arab Israeli conflict. Many of the Palestinian officials support it, but the Israeli officials are more mixed with responses.
Israel begins constructing the west bank barrier
2002-ongoing,started june - Is a part wall, part fence structure, made up of barbed wire, a four meter ditch, an eight meter high wall, and watchtower posts. It is meant to prevent attacks, block bullets, and prevent intruders
Road map for peace proposed
July 16 - The U.S. backed this peace proposal, which was meant to move the Israelis and Arabs into a peaceful era. It had mostly failed, with bombings still occurring, but is believed by some that it can be revived.
Israel disengages from Gaza
2005 August - Israel removed all military from the Gaza Strip, so as to attempt to reduce the terrorism against Israel. As a result of the move, Palestinians became free from the Israeli prejudice and hate, that was in the area.
Hamas is elected
Jan 25 - Winning by majority, the Covenant of the Islamic resistance movement, also very hostile towards the PLO. the U.S, Russia, U.N, E.U made foreign assistance to the PA, only if they remain peaceful.
July 12 - A war between Israel and Hezbollah. Started by a surprise attack on the Israeli border, and also by the capture of several Israeli soldiers. As a result, nearly 1,500 people died, and over 1 million displaced. The soldiers that were captured, were also killed.
Battle of Gaza
June 10-15 - Known as Hamas' takeover, It was when Hamas' men gained complete control over Gaza. This caused the European Commission to call for peace instead of the fighting. It also caused the palestinians to be on the verge of breaking into 2 warring areas, and also caused the execution of the top Fatah Militant in Gaza.
2008-2009 - Dec - A three week conflict between Palestinians and Israelis. Started by military activities by Israel in Gaza, it caused the deaths of around 1,400 people, and Israel being forced to rebuild the damages it had caused.
Gaza Flotilla accident
2010 may 31 - Was a commando raid on an aid flotilla bound for Gaza. the ship was boarded in an attempt to break the naval blockade put up by the palestinians. As a result of the raid, nine activists were killed, and dozens were wounded.
December 2011 - A democratic uprising started in Tunisia, eventually spreading to Egypt, Syria, Yavan, Libya, and other nations. Many countries were hit hard by the uprising, and suffer bad consequences. Some countries turned to democracy after the uprising.
HISTORY OF MIDDLE EAST
Israel and Palestine conflict
Arab- Israeli Conflict
Arab-Israeli Conflict Timeline Project
Israeli and Palestinian conflict
Arab-Israel Conflict
Israel Formation
History of the Israeli-Palestinian Conflict
Arab Israeli Conflict
Arab-Israeli Relations
The Arab-Israeli Conflict Timeline
Timeline of Israel/Palestine Conflict 1880 - 2000


text:
Q: How to make a vhdl Mealy state machine? "I'm programming a VHDL (modelsim) state machine (Mealy's machine)
I found this code on the internet but if I start it it gives me the following error, help me thanks in advance:"
** Error: D:/modelsim_ase/esercizi/prova.vhd(32): near "<=": (vcom-1576) expecting => or '|' or '!'.
** Error: D:/modelsim_ase/esercizi/prova.vhd(46): near "<=": (vcom-1576) expecting => or '|' or '!'.
** Error: D:/modelsim_ase/esercizi/FSM.vhd(85): VHDL Compiler exiting

line:
    when others => next_state <= (others <= 'x');

"the code is as follows:"
VHDL
-- Example of a 5-state Mealy FSM
library ieee;
use ieee.std_logic_1164.all;
entity mealy is
 port (clock, reset: in std_logic;
       data_out: out std_logic;
       data_in: in std_logic_vector (1 downto 0));
end mealy;
architecture behave of mealy is
 type state_values is (st0, st1, st2, st3, st4);
 signal pres_state, next_state: state_values;
begin
-- FSM register
statereg: process (clock, reset)
begin
 if (reset = '0') then
  pres_state <= st0;
  elsif (clock'event and clock ='1') then
    pres_state <= next_state;
  end if;
end process statereg;
-- FSM combinational block
fsm: process (pres_state, data_in)
begin
 case pres_state is
 when st0 =>
  case data_in is
   when "00" => next_state <= st0;
   when "01" => next_state <= st4;
   when "10" => next_state <= st1;
   when "11" => next_state <= st2;
   when others => next_state <= (others <= 'x');
  end case;
  when st1 =>
   case data_in is
    when "00" => next_state <= st0;
    when "10" => next_state <= st2;
    when others => next_state <= st1;
   end case;
  when st2 =>
   case data_in is
    when "00" => next_state <= st1;
    when "01" => next_state <= st1;
    when "10" => next_state <= st3;
    when "11" => next_state <= st3;
    when others => next_state <= (others <= 'x');
   end case;
  when st3 =>
   case data_in is
    when "01" => next_state <= st4;
    when "11" => next_state <= st4;
    when others => next_state <= st3;
   end case;
  when st4 =>
   case data_in is
    when "11" => next_state <= st4;
    when others => next_state <= st0;
   end case;
  when others => next_state <= st0;
 end case;
end process fsm;
-- Mealy output definition using pres_state w/ data_in
outputs: process (pres_state, data_in)
begin
 case pres_state is
  when st0 =>
   case data_in is
    when "00" => data_out <= '0';
    when others => data_out <= '1';
   end case;
  when st1 => data_out <= '0';
  when st2 =>
   case data_in is
    when "00" => data_out <= '0';
    when "01" => data_out <= '0';
    when others => data_out <= '1';
   end case;
  when st3 => data_out <= '1';
  when st4 =>
   case data_in is
    when "10" => data_out <= '1';
    when "11" => data_out <= '1';
    when others => data_out <= '0';
   end case;
  when others => data_out <= '0';
 end case;
end process outputs;
end behave;

A: The following from your code is an error
You have transposed the "=>" symbol in the aggregate that contains only others:
when others => next_state <= (others <= 'x');

The following is also an error since it is the wrong type for your example
If it were appropriate to use an aggregate assignment here (it is not), the arrow should point in the opposite direction (=>) as shown below.  Also note that items in single quotes are case sensitive and that all std_ulogic/std_logic letters are upper case and hence it should be 'X' (also shown).
when others => next_state <= (others => 'X');

You must do this to fix your code
Since next_state has the type, state_values, it should instead be:
when others => next_state <= st0;

In addition, some of your other code is rendering funny, or you are using some of the languages alternative characters («00»).  Rather than this, I would recommend using "00" if your keyboard has the " character:
case data_in is
  when "00" => next_state <= st1;

redpajama_set_name: RedPajamaStackExchange


text:
Q: Multiply label with numbers with textfield with numbers Hope everyone can help me. I´m new in swift.
How can I multiply a label l1 (get data(numbers) from pickerview) with an text field txt (get user input(numbers)). the calculate should be started with a button b. Thanks for help
class Flächenbewehrung : UIViewController, UIPickerViewDataSource, UIPickerViewDelegate {

var pickerDataSource = ["Ø 6","Ø 8"]

@IBOutlet weak var myPicker: UIPickerView!
@IBOutlet weak var myLabel: UILabel!
@IBOutlet var txt: UITextField!

@IBOutlet var l1: UILabel!

@IBAction func b(sender: AnyObject) {

}
override func viewDidLoad() {
    super.viewDidLoad()
    self.view.addGestureRecognizer(self.revealViewController().panGestureRecognizer())
    myPicker?.delegate = self
    myPicker?.dataSource = self
}

func numberOfComponentsInPickerView(pickerView: UIPickerView) -> Int {
    return 1
}

func pickerView(pickerView: UIPickerView, numberOfRowsInComponent component: Int) -> Int {
    return pickerDataSource.count
}

func pickerView(pickerView: UIPickerView, titleForRow row: Int, forComponent component: Int) -> String! {
    return pickerDataSource[row]
}

func pickerView(pickerView: UIPickerView, didSelectRow row: Int, inComponent component: Int) {
    if(row==0)
    {
        myLabel.text = "0,4"
    }
    else if(row==1)
    {
        myLabel.text = "0,6"
    }
}

A: I would simply store the number separately from the labels, in different properties.  So for example you could do:
class Flächenbewehrung : UIViewController, UIPickerViewDataSource, UIPickerViewDelegate {

var pickerDataSource = ["Ø 6","Ø 8"]

@IBOutlet weak var myPicker: UIPickerView!
@IBOutlet weak var myLabel: UILabel!
@IBOutlet var txt: UITextField!
var txtNumber: Double = 0.0 // Update this when you update txt
@IBOutlet var l1: UILabel!
var myLabelNumber: Double = 0.0 // Update this when you update l1
@IBAction func b(sender: AnyObject) {

  let result = txtNumber * myLabelNumber
  println(result) // Just for debug
  // store result somewhere or show it in your interface somehow

}

// ETC....
}

A: I'm still not sure what you mean.
You could do the math operation in pickerView:didSelectRow:
func pickerView(pickerView: UIPickerView, didSelectRow row: Int, inComponent component: Int) {
  var multiplicator : Double = 1.0
  if (row == 0)
  {
    myLabel.text = "0,4"
    multiplicator = 0.4
  }
  else if (row == 1)
  {
    myLabel.text = "0,6"
    multiplicator = 0.6
  }

  let result = multiplicator *  (txt.text! as NSString).doubleValue
  // If you want to display the result in a label use
  // anyLabel.text = "\(result)"
}

the code does not contain any error handling for example is the text value in label txt convertible to Double


Since inception, Big Shoulders Fund's mission has been grounded on the fact that we are for the children. When the opportunity presented itself to expand our reach and help to serve a greater population of students through the Tax Credit Scholarship Program, made possible by the Illinois Invest in Kids Act, we knew that it was something we had to be a part of.
In January of last year, Big Shoulders Fund opened its Tax Credit Scholarship Program application for the first time. From our conversations with school administrators and families, we learned that this initiative would have a positive impact in the lives of many but when the count came in of more than 12,000 applications in two days, we were in awe of the demand for the program. In year one, Big Shoulders awarded nearly $8M in scholarships to more than 1,300 students attending 110 schools. The median household income of our awardees was $22,500, with an average of four family members per household.
To help measure the impact of the program, it was important to us to hear from recipients themselves. An anonymous survey was sent to all recipients of a Big Shoulders Fund Tax Credit Scholarship for the 2018-2019 school year. 473 respondents completed the survey totaling to a response rate of 54 percent.
On January 22, Big Shoulders Fund reopened its Tax Credit Scholarship application for families to apply for scholarships for the 2019-2020 school year. Given the first-come, first-served nature of the program and the limited funding, we knew this could be a stressful process for families. From Facebook Live Q&A's to hosting informational seminars, the Big Shoulders Fund team collaborated to make this a positive experience for applicants. The day the application opened, we set-up a call center in our offices so that parents/guardians could get real-time support on the phone while applying, and hosted five application sites across the City. We received more than 12,000 applications on the first day the application opened, once again reflecting tremendous demand. As of today, 13,100 applicants are on our waitlist. As we receive contributions, we will award scholarships to as many eligible families as possible.
We continue to support and raise funds for this program, because we know the impact. This program expands access to educational options for students. Survey results show that alumni of Big Shoulders Fund schools graduate, work, and donate to charity at a much higher rate than their peers thereby, strengthening their communities and the City as a whole. We here at Big Shoulders Fund, are very proud of what we have been able to accomplish and continue to achieve through the Tax Credit Scholarship Program as well as through our traditional privately funded scholarship program.
The Tax Credit Scholarship Program has added to the support we give the schools. Many of our supporters have stepped up to help us continue to expand. The program has truly been additive and not taken away from funding and support of our private scholarships and the other services we provide our schools each year. We thank you, the supporters, for your continued commitment to our students and our mission. You are truly #paralosniños.
Donors to the Big Shoulders Fund Tax Credit Scholarship Program receive a 75 percent credit, of the total contributed, toward their Illinois income tax. To learn more on how you can participate and make a difference in a child's life this year, please visit www.bigshouldersfund.org/take-action/tax-credit and/or contact Amy Drozda or at 312.751.3850.


text:
LYNWOOD CRASH: Two Girls Killed, Two Boys and Mother Injured in Crash on 710 Freeway
LYNWOOD, California — Two young children were killed and two others injured after a 26-year-old mother crashed the car they were riding in on the Long Beach (710) freeway, according to an article in the Los Angeles Times newspaper.
The unidentified female driver was traveling northbound on the freeway just south of Imperial Highway at what was described as a high rate of speed when she lost control of the black Honda Accord and veered off the roadway down an embankment. The Honda first struck a fence and then lipped over and struck a tree at the bottom of the ditch.
Despite all passengers wearing seat belts, two girls ages 4 and 6 years old died in the car crash. The driver, as well as two boys ages 5 and 8 years old, were injured in the crash and transported to Long Beach Memorial Hospital for treatment. The younger boy was listed in critical condition and the older boy suffered minor injuries in the crash. The mother was also in critical condition at the hospital.
None of the victims have been identified, nor have police confirmed which children are those of the mother.
"Police will likely conduct a full investigation into why this crash took place including whether the vehicle she was driving was defective in any way or if any other vehicles were involved," said Attorney West Thomas, Long Beach personal injury lawyer.
Long Beach Car Accident Law Firm
This article was sponsored by the Thomas Law Firm Personal Injury Attorneys serving those involved in crashes in every Southern California County including Orange County, Los Angeles County, Kern County, Imperial Empire, Long Beach, Riverside County, San Bernardino County, Ventura County, San Diego County and San Francisco County.
The cities we handle include Anaheim, Big Bear City, Buena Park, Colton, Costa Mesa, Fountain Valley, Fullerton, Garden Grove, Huntington Beach, Irvine, Lake Forest, Long Beach, Los Angeles, Newport Beach, Orange, Palm Springs, Riverside, San Bernardino, San Diego, Santa Ana, Torrance, Tustin, Westminster, West Covina, Victorville, Ventura and. Additionally, we have offices to serve clients in Las Vegas, Nevada.
Call us today at 1-855-ASK WEST (1-855-275-9378) to speak with our car accident law firm.
Categories : Car Accident News
Tags : fatal crash, Long Beach 710 freeway, long beach car accident, Long Beach car accident law firm, Long Beach personal injury law firm, Lynwood car accident
Sitemap | ASK WEST | Orange County Personal Injury Attorney

redpajama_set_name: RedPajamaCommonCrawl


text:
Dragon Ball Z: The Legend (PS1)
Gameplay: Fighting
Art: Anime / Manga
Published by: Bandai Co.
Developed by: BEC Co.
Legend uses a game system different from the previous DBZ. Graphics feature 2D sprites in a 3D world. Although each battle begins on the ground, most of the action is in the air.
The characters fly around each other and use fast kicks and kicks, and Ki bursts, either individually or quickly by pressing and holding the assigned button for a short period of time. Characters have a limited amount of Ki that can be exhausted with use and recharged manually or over time. The characters have two bars on the screen that appear next to the image of their face: these are health (green) and ki (yellow) respectively, if the player uses all of his available ki, his character will stop fighting for exhaustion , leaving wide open for an attack.
The life meter of each character does not deteriorate with normal attacks, only Meteor Atacks reduce the life of a character. The "Power Balance" (balance of power) is a scale that appears at the bottom of the screen composed of the energy of both sides that moves according to who is in control of the fight, after one of the sides fill the bar with its color (Red or Blue), the character managed by the player will perform a special "Meteor Atack" (Meteor Attack), which takes place in a cut scene where the opponent is finished with a characteristic attack of the character in question.
Each game is made up of two teams that can include from a wrestler to 3 wrestlers, who can be organized in innumerable combinations; the player can alternate the character he uses during the battle for any other of his team, as well as decide which character of the enemy team to attack. Each character has a personalized costume for each character, this game is also one of the most played games by everyone, the game also has a story mode that deals with any saga of Dragon Ball Z.
Story thread
There are eight "episodes" in the story mode: the saga of the Saiyan, the saga of the Ginyu Special Forces, the saga of Frieza, the saga of the Androids, the saga of the Tournament of Cell, the Saga of Majin Buu, the saga of La Fusión, and the saga of Majin Buu Original (Kid Buu). At the beginning of each episode a screen with the characters available for the same will appear, the player can freely choose between these resulting in unpublished facts.


Today I went my cousins bridal shower. My younger cousins are starting to get married now and the people who threw the shower had never even attended a bridal shower before. It was very well done for a first time party. This was a tame party as family was involved. It was a house party with take out Thai food and very nice cakes made by another cousin I wish I got a picture. The games revealed that the couple have a lot to learn about each other even though they have known each other for fifteen years. I won a prize for getting the most answers right on whether the bride or groom said certain answers. It's kind of interesting that I won because I have only met the groom to be once for a few minutes and I don't spend very much time with my cousin as she is much younger than me. Anyways yeah I won this great prize package. I count this as my first win for 2017. The nailpolish and kisses were a party favour but the rest was the prize.
Earlier in the week I went to the dentist to get a crown I have this tooth that has had everything done to it including sticking a pin in it but nothing worked and the tooth keeps cracking. A crown is just like a filling with more steps it's in the very back of my mouth and my mouth is really small. It's also the side of my mouth that I have had oral surgery on so I can't stretch my mouth out that much. As the dentist was nicely stretching my jaw the freezing only works on the tooth she said she will give me some advil she gave me the equivalent of three. I was like oh I take one very rarely she laughed at me and was like that won't do anything and take at least two more later in the day. Since then I have been super tired just napping or falling asleep on the couch whenever I am home. I don't know if its from the dentist or work stress or something else but I haven't done much else this week.
The last two weeks I have been craving a piece of tiramisu not a whole cake and not the kind that you can get at the asian stores. I can make tiramisu I used to make it when I worked in a restaurant but I just wanted a piece and didn't want to buy ingredients to make it. I have looked in every place that could sell it in downtown or Coquitlam but couldn't find what I wanted. I finally found it yesterday at Him and I cafe in Coquitlam. It is so satisfying when you find what you have been looking for so long. It was exactly what I wanted and so good.
After the dentist I was craving soup but couldn't figure out where to get some from then I remembered I had a soup maker why buy soup. I thought I had some butternut squash in the freezer but I didn't so I ended up using frozen europe's best veggies.
I put the whole bag of europe's Best, the vegetable broth, and half an onion in the soup maker and set it to smooth.
I added some cream to the bowl and it made it so much better.


text:
HomeCHICAGOEntertainmentA Christmas Carol Review – Fresh and Evergreen
A Christmas Carol Review – Fresh and Evergreen
November 29, 2021 Jessie Bond Entertainment 0
(L-R) Grier Burke, Paris Strickland, Gayatri Gadhvi, Rika Nishikawa, Nelson H. Simmons dance with the ACC Ensemble
It's been a long, difficult two years since the Goodman Theatre last presented its annual stage adaptation of A Christmas Carol and, like all of us, the show has changed in that time. Most notably, the production has a new director, Jessica Thebus, who directed the audio version released in 2020. The show remains recognizable, down to favorite acting choices by longtime Scrooge actor Larry Yando, but Thebus' direction gently reshapes the familiar play to create something genuinely fresh and deeply resonant.
(L-R) Susaan Jamshidi (Mrs. Cratchit) Gayatri Gadhvi (Tiny Tim) Thomas J. Cox (Bob Cratchit) Nelson H. Simmons (Peter Cratchit)
One holdover from the show's conversion to an audio format is the addition of more narration. This is a welcome change, as it allows for further development of the show's atmosphere and prevents the awkwardness of the narrator disappearing for the majority of the play as they have done in years past. The four spirits who visit Scrooge have all been revamped to varying degrees: Jacob Marley is much more heavily burdened by the weight of his chains, and the Ghost of Christmas Future takes on an eerie avian element. Even more noticeably changed, however, are the Ghost of Christmas Past and Ghost of Christmas Present. The Ghost of Christmas Past moves away from the colorful circus interpretation of previous years and towards something more ethereal and heavenly. Actor Lucky Stiff brings as much sparkle to the character as their costume (designed by Heidi Sue McMath) brings to the stageーand that's a lot of sparkle. The Ghost of Christmas Present, played with charm and high energy by Bethany Thomas, arrives bedecked in evergreens, a tribute to Celtic and Druidic imagery that is delightfully decadent.
Larry Yando (Ebenezer Scrooge)
Diversity in casting has been important to this production since I've been reviewing it, and this year the inclusivity is stronger than ever. The cast is racially diverse, and even more women grace the stage than in years past. Most notably, the character of Mr. Fezziwig, Scrooge's former mentor, is recast as Mrs. Maud Fezziwig, but his wife, Mrs. Alice Fezziwig, remains female. The brief but utterly charming interactions between Cindy Gold and Penelope Walker as the two Mrs. Fezziwigs are a heartwarming highlight of the production.
(L-R) Thomas J. Cox (Ensemble) Penelope Walker (Mrs. Alice Fezziwig) Ariana Burks (Ensemble) Cindy Gold (Mrs. Maud Fezziwig) Christopher Sheard (Young Scrooge) Rika Nishikawa (Ensemble)
Larry Yando is, as always, a triumph as Scrooge. Every moment of Scrooge's transformation, from his early misanthropy and viciousness to his giddiness and generosity in the final scenes is fully embodied and utterly believable. Other cast highlights include Kareem Bandealy, who is deeply unsettling as Jacob Marley; Dee Dee Batteast, who is charismatic and lovable as Scrooge's niece Frida; and Andrew White, who elevates the Narrator from a mere dispenser of information to a compelling character in his own right.
Kareem Bandealy (Jacob Marley)
Todd Rosenthal's sets remain a visual feast. A few scenes have been wisely pared down, including my least favorite from the Christmas Future section, when Scrooge's belongings are sold to a questionable shopkeeper. Even the Ignorance and Want, represented by two children brought forth by the Ghost of Christmas Present, whose scene is typically another low point in the show, have somehow become more engaging in Thebus' production.
(L-R) Larry Yando (Ebenezer Scrooge) Thomas J. Cox (Bob Cratchit)
Going to the theatre is different than it once was. To enjoy A Christmas Carol this year, you'll need to don a mask and provide proof of vaccination or a negative COVID test at the door. But the best parts of theatreーthe brilliant acting, the gorgeous design work, the overall feeling of magicーnot only remain, but shine brighter than ever. Jessica Thebus has breathed new life into a beloved production, and it is absolutely wonderful to behold.
Location: The Goodman Theatre, 170 N Dearborn Street, Chicago, IL 60601
Dates: November 29-December 31, 2021
Tickets: $25-$141. Available at GoodmanTheatre.org/Carol or by phone at 312.443.3800. For full safety protocols, visit GoodmanTheatre.org/Protocols. For accessibility, including touch tour and closed caption performances, visit GoodmanTheatre.org/Access.
All photos by Liz Lauren.
How About It for Love Actually?
Dickens Fair Drive Thru
The Goat, Or Who Is Sylvia? Review – Absurdity & Darkness
September 20, 2018 Jessie Bond Entertainment 0
Spread the loveLook, he f*cks the goat. There's no way around it. The play tells us so, very explicitly, pretty much up front. I went into The Goat, Or Who Is Sylvia?, currently in production […]
Coronado Playhouse Review – The Addams Family Come To The Beach
January 24, 2018 Kathy Carpenter Entertainment 0
Spread the loveBy Kathy Carpenter Coronado Playhouse one of the longest running community thaters in San Diego starts it's 72nd season: It's a Family Affair with The Addams Family A New Musical. Within seconds of […]
Hamlet Review – A Hit, A Very Palpable Hit!
June 10, 2018 Jessie Bond Entertainment 0
Spread the loveProducing Hamlet in the year 2018 is a daunting task. Widely considered one of the greatest works of literature in the English language, Shakespeare's masterpiece has been produced countless times in the 415 […]


Sell used Bond-Eye Australia online with up to 90% payouts at thredUP. Be it one piece swimsuit or swimsuit bottoms, we will find a new home for things you do not need anymore.
How much will I earn when selling my Bond-Eye Australia clothes?


text:
Greyia flanaganii, commonly known as the Kei bottlebrush, is a species of plant in the Francoaceae family. Greyia flanaganii is one of the related species of the taxonomically isolated and endemic southern African family, the Greyiaceae. Greyia flanaganii is  endemic to southeastern South Africa. It is named after Henry George Flanagan, a South African farmer and botanist from Komga, Eastern Cape, South Africa.

Description
It is more often a shrub than a small tree. The lower side of the leaves are covered in dense hairs, similar to those of the woolly bottlebrush, but the leaves are less strongly lobed around the base.

Range
It is present in the hills and rocky valleys around Grahamstown, but may be found from Queenstown to Komga in the Eastern Cape. It is indicated as rare on the SANBI red data list, but is not threatened by extinction. They are usually found growing as individuals, and are distributed in about 10 known subpopulations.

Relationships
The two related species in Greyiaceae, namely Greyia radlkoferi and Greyia sutherlandii are dormant and leafless in winter, unlike Greyia flanaganii, which is evergreen. Greyia  radlkoferi is found in the Mpumalanga and eastern Limpopo provinces South Africa, while Greyia sutherlandii is from KwaZulu-Natal, South Africa. The greyias of South Africa do not appear to have close similarities with other plant genera in the world, and some botanists support a theory that they deserve a separately place in the world of trees. Greyiaceae was formerly placed in a monotypic order between the Saxifragales and Francoyales.

References

Endemic flora of South Africa
flanaganii
Data deficient plants
Taxonomy articles created by Polbot

redpajama_set_name: RedPajamaWikipedia


text:
The waffling continues. Thanks to Gay News Bits:
Asked on Tuesday if the White House would consider halting gay discharges by presidential authority, press secretary Robert Gibbs said it would not stop the firing of gay troops.
That said, Gibbs insisted that the President believes that the "don't ask, don't tell" policy "isn't working for our national interests" and that he "will work with the Joints Chiefs of Staff, the administration and with Congress" to change the policy.
In recent weeks, the President's national security team has sent mixed messages. Defense Secretary Robert Gates spoke of what action would occur "if" the policy were repealed, suggesting it may not be; and national security advisor James Jones said this weekend he was not sure if the ban would be lifted.
This appears to be a direct message to all current LGBTQ armed service members: as of right now, you will still be discharged if you come out. Sorry, Lt. Dan Choi, it seems you will, indeed, be fired. The news comes on the back of the Palm Center releasing a study by legal experts stating that yes, in fact, Pres. Obama could end Don't Ask, Don't Tell with an executive order.
I think I'm just about out of commentary on this particular topic. That's ok, though, because Andrew Sullivan said it better:
Here we are, in the summer of 2009, with gay servicemembers still being fired for the fact of their orientation. Here we are, with marriage rights spreading through the country and world and a president who cannot bring himself even to acknowledge these breakthroughs in civil rights, and having no plan in any distant future to do anything about it at a federal level. Here I am, facing a looming deadline to be forced to leave my American husband for good, and relocate abroad because the HIV travel and immigration ban remains in force and I have slowly run out of options (unlike most non-Americans with HIV who have no options at all).
And what is Obama doing about any of these things? What is he even intending at some point to do about these things? So far as I can read the administration, the answer is: nada. We're firing Arab linguists? So sorry. We won't recognize in any way a tiny minority of legally married couples in several states because they're, ugh, gay? We had no idea. There's a ban on HIV-positive tourists and immigrants? Really? Thanks for letting us know. Would you like to join Joe Solmonese and John Berry for cocktails? The inside of the White House is fabulous these days.
Yesterday, Robert Gibbs gave non-answer after non-answer on civil unions and Obama's clear campaign pledge to grant equal federal rights for gay couples; non-answer after non-answer on the military's remaining ban on honest servicemembers. What was once a categorical pledge is now - well let's call it the toilet paper that it is. I spent yesterday trying to get a better idea of what's intended on all fronts, and the overwhelming sense - apart from a terror of saying anything about gay people on the record - is that we are in the same spot as in every Democratic administration: the well-paid leaders of the established groups get jobs and invites, and that's about it. Worse: we will get a purely symbolic, practically useless hate crimes bill that they will then wave in our faces to prove they need do nothing more.
Whoa dude. Whoa.
Posted by Barry Floore at 5/14/2009 04:06:00 AM
Labels: Barack Obama, DADT
I was willing to give Obama some slack, given that it has been just 4 months. But the more I see this administration taking everything on at once -- just now launching into their health care initiative -- the more I am thinking, well, if you are going to do it all at once, bravo, DO THIS. Why must DADT, which 75% of the public supports repeal of, wait? What needs to be studied? It is not some complicated program that must be carefully nuanced -- it is a fucking repeal of discrimination, blazingly simple. DO IT.
Which Stars Are Going To Blow Up In Super Bowl LVII?


text:
package org.apache.hadoop.hive.serde2.objectinspector.primitive;

import junit.framework.TestCase;

import org.apache.hadoop.hive.serde2.objectinspector.PrimitiveObjectInspector;
import org.apache.hadoop.hive.serde2.objectinspector.PrimitiveObjectInspector.PrimitiveCategory;

public class TestPrimitiveObjectInspectorFactory extends TestCase {

  public void testGetPrimitiveWritableObjectInspector() {
    // even without type params, return a default OI for varchar
    PrimitiveObjectInspector poi = PrimitiveObjectInspectorFactory
        .getPrimitiveWritableObjectInspector(PrimitiveCategory.VARCHAR);
    assertEquals(poi, PrimitiveObjectInspectorFactory.writableHiveVarcharObjectInspector);

    // Same for char
    poi = PrimitiveObjectInspectorFactory
        .getPrimitiveWritableObjectInspector(PrimitiveCategory.CHAR);
    assertEquals(poi, PrimitiveObjectInspectorFactory.writableHiveCharObjectInspector);
  }

  public void testGetPrimitiveJavaObjectInspector() {
    // even without type params, return a default OI for varchar
    PrimitiveObjectInspector poi = PrimitiveObjectInspectorFactory
        .getPrimitiveJavaObjectInspector(PrimitiveCategory.VARCHAR);
    assertEquals(poi, PrimitiveObjectInspectorFactory.javaHiveVarcharObjectInspector);

    // same for char
    poi = PrimitiveObjectInspectorFactory
        .getPrimitiveJavaObjectInspector(PrimitiveCategory.CHAR);
    assertEquals(poi, PrimitiveObjectInspectorFactory.javaHiveCharObjectInspector);
  }
}

redpajama_set_name: RedPajamaGithub


text:
GENOMIC VISION AND EUROPEAN EQUITY PARTNERS ENTER INTO AGREEMENT TO USE MOLECULAR COMBING AS A GENOME INTEGRITY ASSAY IN THE FIELD OF BIOMANUFACTURING
• Genomic Vision grants European Equity Partner (EEP) a license to its proprietary technology.
• During the evaluation period, the parties will confirm interest of molecular combing as a genome integrity assay as a quality control tool in biomanufacturing of proteins
• This strategic collaboration is aimed at building a Bioanalytical Services Company offering specific leading analytical services in bioprocessing.
Bagneux (France), August 9, 2018 – 7.45 am (CEST)– Genomic Vision (FR0011799907 – GV), a company specializing in the development of diagnostic tests for the early detection of cancers and hereditary diseases, and applications for life sciences research, today announces that it has entered into a licensing agreement with European Equity Partners (EEP), a U.K private investment firm focused on life science investments, to use molecular combing technology within the bioprocessing domain.
Pursuant to this agreement, the parties will enter into a period during which they will confirm that the Combing Genome Integrity assay can replace or complete existing quality control test in Bioprocessing.
Followed a conclusive development program the two parties plan to establish of a new entity dedicated to applications of the Combing Genome Integrity assay in Biomanufacturing. This entity will have an exclusive license to Genomic Vision's proprietary Molecular Combing technology in the field of Biomanufacturing.
The new company willoffer a mixed model of analytical services as well as license agreements to strategic partners using Genome Integrity Assay for the production of biological products such as therapeutic proteins, monoclonal or polyclonal antibodies, vaccines and viral particles.
In exchange of the license right, Genomic Vision will receive an upfront, milestones payments (amounting to a total of more than 500 k€) as well as royalties on sales and services (other financial terms not disclosed).
David Kauffmann, founder partner of European Equity Partners, said: "We believe in the potential of the Genomic Vision proprietary technology for controlling the quality of Bioproduction where there is an important unmet need for new assays allowing the identification and quantification of genomic instability in cell populations. We are very excited by the idea of setting up analytical solutions based on this technology that will be perfectly adapted as quality control tool for cell banks clonality. These solutions will pave the way to better selection of appropriate clones and should lead to the improvement of cost effectiveness in process development and manufacturing".
Stephane Altaba, Vice President Corporate Development of Genomic Vision, added: « We are very pleased of this partnership with EEP who has a great knowhow and knowledge in building business in the bioprocessing domain, in particular in the manufacturing of biological products. This agreement confirms the potential of the combing technology in monitoring genome instability for therapeutic recombinant proteins and monoclonal antibodies production – as we already demonstrated its benefits in gene editing with our partnership with Editas Medecine. In addition, with a new service activity in the field of Biomanufacturing, Genomic Vision has the opportunity to access a high added value and recurrent service revenue stream. We are looking forward to progress with EEP to create a new way to find innovative solutions to improve and secure quality of bioproduction for the benefit of pharma manufacturers and patients".
ABOUT EUROPEAN EQUITY PARTNERS
Based in London (United Kingdom), European Equity Partner (EEP) is a private investment firm focused on life science investments. It selectively looks to invest in small and mid-sized life science companies. The prospect of growth, proven business traction and a demonstrated promising business model are key investment parameters for EEP. As an active shareholder, EEP favours companies where its experience can assist management accelerate growth and optimize results. For further information, please visit:www.eeplp.com
THE ABOUT GENOMIC VISION
GENOMIC VISION is a company specialized in the development of diagnostic solutions for the early detection of cancers and serious genetic diseases and tools for life sciences research. Through the DNA Molecular Combing, a strong proprietary technology allowing to identify genetic abnormalities, GENOMIC VISION stimulates the R&D productivity of the pharmaceutical companies, the leaders of the diagnostic industry and the research labs.
The Company develops a robust portfolio of diagnostic tests (breast, ovarian and colorectal cancers, myopathies) and analysis tools (DNA replication, biomarkers discovery, gene editing quality control). Based near Paris, in Bagneux, the Company has approximately 50 employees. GENOMIC VISION is a public listed company listed in compartment C of Euronext's regulated market in Paris (Euronext: GV – ISIN: FR0011799907). For further information, please visit www.genomicvision.com
Genomic Vision
Aaron Bensimon
Co-fondateur et Président du Directoire
investisseurs@genomicvision.com
Ulysse Communication
Bruno Arabian
Tel. : +33 1 42 68 29 70
barabian@ulysse-communication.com
NewCap
Investor Relations & Strategic Communications
gv@newcap.eu
This press release contains implicitly or explicitly certain forward-looking statements concerning Genomic Vision and its business.
Such forward-looking statements are based on assumptions that Genomic Vision considers to be reasonable. However, there can be no assurance that such forward-looking statements will be verified, which statements are subject to numerous risks, including the risks set forth in the "Risk Factors" section in its Document de Reference filed with the French Autorité des Marchés Financiers (AMF) on March 28, 2017, under number R.17-009, available on the web site of Genomic Vision (www.genomicvision.com) and to the development of economic conditions, financial markets and the markets in which Genomic Vision operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Genomic Vision or not currently considered material by Genomic Vision. The occurrence of all or part of such risks could cause actual results, financial conditions, performance or achievements of Genomic Vision to be materially different from such forward-looking statements.
This press release and the information contained herein do not constitute and should not be construed as an offer or an invitation to sell or subscribe, or the solicitation of any order or invitation to purchase or subscribe for Genomic Vision shares in any country. The distribution of this press release in certain countries may be a breach of applicable laws. The persons in possession of this press release must inquire about any local restrictions and comply with these restrictions.


text:
Walsh open-minded on recruiting from Super Rugby for Tokyo Games
Men's wrap
By Georgina Robinson
Men's sevens coach Tim Walsh says he is happy with the current crop of Australian players but has not ruled out recruiting a Super Rugby star for the run into the Tokyo Olympics next year.
With Olympic qualification on the line in the current World Series, Australia are looking more and more like they will be battling South Africa and England to finish fourth on the table and secure one of the automatic qualifier berths.
Too good: Mesulame Kunavula scores for Fiji in their victory over Australia at Spotless Stadium. Credit:AAP
Australia were dominant at times during the tournament and took the battle to the Flying Fijians in the first quarter-final, opening the scoring then level-pegging until the visitors ran away with it 22-17 in the closing minutes.
At other times they lacked urgency and physicality, and were hit against Fiji when Maurice Longbottom and Josh Coward – very similar attacking threats – both limped off injured.
Australia scaped into the play-off for fifth spot, with competition points at stake, by beating France 17-14. However, they subsequently lost the play-off to South Africa 12-10.
Walsh said he was happy with the squad composition after augmenting his predecessor Andy Friend's assembly with key recruits such as Nick Malouf, Henry Hutchison and Michael Wells. But he said he was always open to recruiting the right player from Super Rugby.
"We wouldn't say no to some of the best players in the world, which are in Australia, but happy with what we've got and where they're progressing to," Walsh said.
The cross-format debate looked to be dead and buried after Quade Cooper failed to make the grade ahead of the Rio Olympics and Friend concentrated on bringing through sevens specialists.
Close but no cigar: Quade Cooper's stint in the Australian sevens set up was short-lived. Credit:AP
But Walsh has shown he is a fan of players who spend time in XVs and sevens, with Wells and Malouf both playing professionally in XVs before returning to the shortened format.
In the complex architecture of the World Series, Australia's Olympic qualification case was helped when England beat South Africa 26-5 in the fourth quarter-final at Spotless Stadium on Sunday.
New Zealand made it a double celebration after the Black Ferns won the women's title when the men's team beat the United States 21-5 in the final on Sunday night to be crowned Sydney champions.
"The top three [New Zealand, USA and Fiji] seem to be getting away so it is pretty much at this stage a fight for fourth," Walsh said.
"It wasn't a bad thing that England beat South Africa, because South Africa were a bit ahead of England overall. We beat South Africa so we'll get some points there, England will get further ahead but overall it's not as bad. It's really important that we scrap for every point."
Australia rugby
Georgina Robinson
Georgina Robinson is the chief rugby reporter for The Sydney Morning Herald.


Please feel free to call us with questions. We welcome you to our campground and we look forward to seeing you. Come sit with us on the Tuckasegee River. We have a swimming pool, camping cabins, tents, RVs, pop-ups. Open all year. Pet-friendly.


text:
Pabst, MillerCoors locked in legal battle
Pabst owners claim MillerCoors breached agreement to brew Pabst products.
Pabst, MillerCoors locked in legal battle Pabst owners claim MillerCoors breached agreement to brew Pabst products. Check out this story on postcrescent.com: http://post.cr/1T0U312
Bruce Vielmetti, Milwaukee Journal Sentinel Published 12:06 p.m. CT May 5, 2016
Two companies steeped in Milwaukee history, Pabst Brewing (historic plant, left) and MillerCoors (right), are embroiled in a legal battle over MillerCoors' commitment to brewing Pabst brands(Photo: File/Milwaukee Journal Sentinel)
Early last year, Pabst Brewing Co. was flirting with a return to its roots, exploring launching a microbrewery at the historic Pabst plant in 2016.
Instead, Pabst has come back to Milwaukee to wage a high-stakes legal battle against hometown heavy hitter MillerCoors LLC.
Pabst and its owner, Los Angeles-based Blue Ribbon Intermediate Holdings LLC, claim in a lawsuit filed in circuit court that MillerCoors breached a long-term agreement to brew Pabst products without warning and after repeated assurances that MillerCoors had sufficient capacity to honor the deal into the next decade.
The lawsuit characterized MillerCoors' moves "an improper attempt to frustrate Pabst's contract rights, sabotage Pabst's ability to compete and consolidate MillerCoors' already large market share."
Losing the chance to extend the agreement, Pabst says, will cost the company some $400 million in damages.
"We expect this issue to be resolved in our favor, and that it will not affect Pabst's long-term ability to brew," Pabst spokeswoman Alya Wilhelm said.
"The innovation brewery is still slated to open as planned and is unaffected by this suit," referring to Pabst's plans to open a microbrewery and tasting room at the old Pabst plant in Milwaukee.
The future microbrewery and tasting room, as well as a restaurant, will be in a building at 1037 W. Juneau Ave. that was initially built as a church. Pabst later used it as an employee conference center.
The building was sold in December to an affiliate of Blue Ribbon Management LLC, which will lease that space to Pabst. Blue Ribbon in April received several city building permits to proceed with the redevelopment project.
MillerCoors spokesman Jonathan Stern said, "We are aware of the lawsuit but can't comment at this time."
According to the lawsuit, current Pabst CEO Eugene Kashper relied on MillerCoors' assurances about the viability of its deal to brew and package Pabst products when he and another company formed Blue Ribbon Intermediate Holdings and bought Pabst in November 2014.
It says talks on extending the 2007 agreement five years beyond 2020 began normally last year. But during the negotiations, MillerCoors announced it would closing its Eden, N.C., brewery, where most of the Pabst products are made, and told Pabst it would no longer have sufficient beer production capacity to meet the agreement.
The only way to continue the deal, Pabst claims it was told, was if the fee paid to MillerCoors after 2020 nearly tripled. Pabst's suit calls the offer a poison pill meant to "effect the premature termination of the agreement."
MillerCoors experienced a change of leadership last summer, when Gavin Hattersley replaced Tom Long as CEO. In September, Pabst claims, Hattersley began backtracking on claims about capacity and his company's willingness to extend the agreement, and then announced the North Carolina closure.
MillerCoors, which has been brewing Pabst products since 1999, suddenly claimed it makes no profit on the endeavor, which Pabst calls "facially false and made in bad faith."
The lawsuit makes seven claims, including for breach of good faith and fair dealing, strict liability for misrepresentation, fraud and negligence.
Pabst initially filed the action under seal, citing the fact that a 2007 brewing agreement between the companies, and its many amendments, are attached as exhibits, and a provision of the agreement calls for it to be confidential.
But the judge who drew the case, Milwaukee County Circuit Judge David Borowski, never granted the motion to keep the complaint under seal. Late last month, MillerCoors sought to have the case moved to a different judge.
Pabst traces its history to 1848, when Jacob Best opened the brewery with the capacity to brew 18 barrels per batch. Today, the Pabst umbrella covers everything from Old Milwaukee, Old Style and Old Tankard Ale to Schmidt's, Stag and Schaefer.
MillerCoor's footprint in Milwaukee began in 1855, when Frederick Miller settled in Milwaukee, leased and later purchased the Plank Road Brewery. Today, 99 beers fall under MillerCoors, including all the beers under the Miller, Leinenkugels, Coors, Blue Moon, Henry Weinhard's and Molsen labels.
Tom Daykin of the Journal Sentinel staff contributed to this report.
Read or Share this story: http://post.cr/1T0U312


Here's the list of cruelty-free and non-toxic makeup brands.
Cinnamon can improve brain activity, which boosts cognitive processing therefore cinnamon enhances your memory, attention, and visual/motor speed.
Gold, navy and white are such a classic combination of colors.


text:
Diagnosis and prevalence of lanolin allergy
Rachel Y.N. Miest, James A. Yiannias, Yu Hui H. Chang, Nidhi Singh
Background: Current evaluation of suspected allergic contact dermatitis to lanolin includes patch testing to lanolin alcohol (30% in petrolatum). Using this method, the prevalence of lanolin allergy is low (1.8%-2.5%). Objective: The objective of this study was to determine whether patch testing to a single lanolin derivative results in underdiagnosis compared with patch testing to 12 lanolin derivatives. Methods: Patients were prospectively patch tested to (1) lanolin alcohol (30% in petrolatum) in our standard allergen series; (2) Amerchol L101 (50% in petrolatum) in our cosmetic series; and (3) 10 lanolin derivatives (using concentrations and vehicles recommended in the literature) in a supplemental series. Results: Of 286 patients, the overall prevalence of positive reactions to lanolin in at least 1 of the 3 patch test series was 6.29% (95% confidence interval [CI], 3.48%-9.11%) (n = 18). The prevalence rates of lanolin allergy using the standard, cosmetic, and supplemental series were 1.05% (95% CI, 0%-2.23%), 3.85% (95% CI, 1.62%-6.07%), and 3.85% (95% CI, 1.62%-6.07%), respectively. Amerchol L101 was associated with increased reaction rates compared with the standard (odds ratio, 3.81; P = 0.007) and supplemental (odds ratio, 8.85; P G 0.001) series, whereas reaction rates were similar for the standard and supplemental series (P = 0.78). Conclusions: Amerchol L101 and patients' own products should be added to a standard patch testing allergen series to adequately identify lanolin allergy.
https://doi.org/10.1097/DER.0b013e3182937aa4
10.1097/DER.0b013e3182937aa4
Dive into the research topics of 'Diagnosis and prevalence of lanolin allergy'. Together they form a unique fingerprint.
Lanolin Medicine & Life Sciences 100%
Hypersensitivity Medicine & Life Sciences 48%
Amerchol L101 Medicine & Life Sciences 39%
Petrolatum Medicine & Life Sciences 24%
Allergens Medicine & Life Sciences 11%
Alcohols Medicine & Life Sciences 8%
Odds Ratio Medicine & Life Sciences 7%
Miest, R. Y. N., Yiannias, J. A., Chang, Y. H. H., & Singh, N. (2013). Diagnosis and prevalence of lanolin allergy. Dermatitis, 24(3), 119-123. https://doi.org/10.1097/DER.0b013e3182937aa4
Diagnosis and prevalence of lanolin allergy. / Miest, Rachel Y.N.; Yiannias, James A.; Chang, Yu Hui H. et al.
In: Dermatitis, Vol. 24, No. 3, 05.2013, p. 119-123.
Miest, RYN, Yiannias, JA, Chang, YHH & Singh, N 2013, 'Diagnosis and prevalence of lanolin allergy', Dermatitis, vol. 24, no. 3, pp. 119-123. https://doi.org/10.1097/DER.0b013e3182937aa4
Miest RYN, Yiannias JA, Chang YHH, Singh N. Diagnosis and prevalence of lanolin allergy. Dermatitis. 2013 May;24(3):119-123. doi: 10.1097/DER.0b013e3182937aa4
Miest, Rachel Y.N. ; Yiannias, James A. ; Chang, Yu Hui H. et al. / Diagnosis and prevalence of lanolin allergy. In: Dermatitis. 2013 ; Vol. 24, No. 3. pp. 119-123.
@article{77ed171398ec46ed9b53247c57e11cc0,
title = "Diagnosis and prevalence of lanolin allergy",
abstract = "Background: Current evaluation of suspected allergic contact dermatitis to lanolin includes patch testing to lanolin alcohol (30% in petrolatum). Using this method, the prevalence of lanolin allergy is low (1.8%-2.5%). Objective: The objective of this study was to determine whether patch testing to a single lanolin derivative results in underdiagnosis compared with patch testing to 12 lanolin derivatives. Methods: Patients were prospectively patch tested to (1) lanolin alcohol (30% in petrolatum) in our standard allergen series; (2) Amerchol L101 (50% in petrolatum) in our cosmetic series; and (3) 10 lanolin derivatives (using concentrations and vehicles recommended in the literature) in a supplemental series. Results: Of 286 patients, the overall prevalence of positive reactions to lanolin in at least 1 of the 3 patch test series was 6.29% (95% confidence interval [CI], 3.48%-9.11%) (n = 18). The prevalence rates of lanolin allergy using the standard, cosmetic, and supplemental series were 1.05% (95% CI, 0%-2.23%), 3.85% (95% CI, 1.62%-6.07%), and 3.85% (95% CI, 1.62%-6.07%), respectively. Amerchol L101 was associated with increased reaction rates compared with the standard (odds ratio, 3.81; P = 0.007) and supplemental (odds ratio, 8.85; P G 0.001) series, whereas reaction rates were similar for the standard and supplemental series (P = 0.78). Conclusions: Amerchol L101 and patients' own products should be added to a standard patch testing allergen series to adequately identify lanolin allergy.",
author = "Miest, {Rachel Y.N.} and Yiannias, {James A.} and Chang, {Yu Hui H.} and Nidhi Singh",
doi = "10.1097/DER.0b013e3182937aa4",
journal = "Dermatitis",
publisher = "Decker Publishing",
T1 - Diagnosis and prevalence of lanolin allergy
AU - Miest, Rachel Y.N.
AU - Yiannias, James A.
AU - Chang, Yu Hui H.
AU - Singh, Nidhi
N2 - Background: Current evaluation of suspected allergic contact dermatitis to lanolin includes patch testing to lanolin alcohol (30% in petrolatum). Using this method, the prevalence of lanolin allergy is low (1.8%-2.5%). Objective: The objective of this study was to determine whether patch testing to a single lanolin derivative results in underdiagnosis compared with patch testing to 12 lanolin derivatives. Methods: Patients were prospectively patch tested to (1) lanolin alcohol (30% in petrolatum) in our standard allergen series; (2) Amerchol L101 (50% in petrolatum) in our cosmetic series; and (3) 10 lanolin derivatives (using concentrations and vehicles recommended in the literature) in a supplemental series. Results: Of 286 patients, the overall prevalence of positive reactions to lanolin in at least 1 of the 3 patch test series was 6.29% (95% confidence interval [CI], 3.48%-9.11%) (n = 18). The prevalence rates of lanolin allergy using the standard, cosmetic, and supplemental series were 1.05% (95% CI, 0%-2.23%), 3.85% (95% CI, 1.62%-6.07%), and 3.85% (95% CI, 1.62%-6.07%), respectively. Amerchol L101 was associated with increased reaction rates compared with the standard (odds ratio, 3.81; P = 0.007) and supplemental (odds ratio, 8.85; P G 0.001) series, whereas reaction rates were similar for the standard and supplemental series (P = 0.78). Conclusions: Amerchol L101 and patients' own products should be added to a standard patch testing allergen series to adequately identify lanolin allergy.
AB - Background: Current evaluation of suspected allergic contact dermatitis to lanolin includes patch testing to lanolin alcohol (30% in petrolatum). Using this method, the prevalence of lanolin allergy is low (1.8%-2.5%). Objective: The objective of this study was to determine whether patch testing to a single lanolin derivative results in underdiagnosis compared with patch testing to 12 lanolin derivatives. Methods: Patients were prospectively patch tested to (1) lanolin alcohol (30% in petrolatum) in our standard allergen series; (2) Amerchol L101 (50% in petrolatum) in our cosmetic series; and (3) 10 lanolin derivatives (using concentrations and vehicles recommended in the literature) in a supplemental series. Results: Of 286 patients, the overall prevalence of positive reactions to lanolin in at least 1 of the 3 patch test series was 6.29% (95% confidence interval [CI], 3.48%-9.11%) (n = 18). The prevalence rates of lanolin allergy using the standard, cosmetic, and supplemental series were 1.05% (95% CI, 0%-2.23%), 3.85% (95% CI, 1.62%-6.07%), and 3.85% (95% CI, 1.62%-6.07%), respectively. Amerchol L101 was associated with increased reaction rates compared with the standard (odds ratio, 3.81; P = 0.007) and supplemental (odds ratio, 8.85; P G 0.001) series, whereas reaction rates were similar for the standard and supplemental series (P = 0.78). Conclusions: Amerchol L101 and patients' own products should be added to a standard patch testing allergen series to adequately identify lanolin allergy.
U2 - 10.1097/DER.0b013e3182937aa4
DO - 10.1097/DER.0b013e3182937aa4
JO - Dermatitis
JF - Dermatitis


text:
Home | Business News | CBJ Newsmakers | POET Sale of DenseLight Subsidiary to Close on or before November 8
POET Sale of DenseLight Subsidiary to Close on or before November 8
SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) — POET Technologies Inc. ("POET" or the "Company") (OTCQX: POETF; TSX Venture: PTK), the designer and developer of the POET Optical Interposer and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today announced that the Closing of the sale of the Company's subsidiary, DenseLight Semiconductors Pte. Ltd. ("DenseLight") to DenseLight Semiconductor Technology (Shanghai) Co. Ltd (the "Buyer" or "DL Shanghai") will close on or before Friday, November 8, 2019.
Widely reported instances of more strict and careful review of foreign currency conversion applications by regulators in the Peoples Republic of China (PRC) have curtailed several forms of foreign investment by Chinese investors and prolonged the Overseas Direct Investment ("ODI") process1. In the case of the sale of the shares of DenseLight to the Buyer, the result is a short delay in the ODI process and subsequent transfers needed to make the first tranche payment of US$8 million to the Company. With the extended review process likely to continue for some time, and to ensure that all interested investors in DL Shanghai are able to participate, the Company has agreed to receive the total purchase price of US$26 million in three tranches, with the first being a payment of US$8 million on or before November 8, plus two additional installments of US$13 million on or before December 31, 2019 and another for US$5 million on or before May 31, 2020. The additional US$2 million to be paid on behalf of the Buyer to Oak Capital for due diligence, legal and other expenses will be made to POET and remitted to Oak Capital with the second tranche payment. The Buyer has provided documentary evidence that the funds needed for the first tranche payment are present in its accounts and will continue to inform the Company on the status of its ODI applications, conversion to US dollars and associated bank transfers. The sale will close upon receipt of the US$8 million into POET's account.The Company also announced that it had received final approval for the sale transaction from the TSX Venture Exchange and confirmed, as previously agreed between the Buyer and the Company, that DL Shanghai will be responsible for the operating expenses of DenseLight Singapore beginning on November 1, 2019.About POET Technologies Inc.
POET Technologies is the designer and developer of optical engines based on its innovative Optical Interposer platform. The POET Optical Interposer is a flexible, proven approach to integrating electronics and photonics in a single chip-scale package which is assembled, tested and singulated at wafer-scale, providing dramatic reductions in the cost and unparalleled design flexibility to address a range of applications, from pluggable transceivers to on-chip photonics for data centers, servers built for artificial intelligence and machine learning and advanced consumer products. POET believes that its Optical Interposer provides an opportunity for the Company to become a global leader in chip-scale photonics. POET is headquartered in Toronto, with operations in Ottawa, Silicon Valley, the United Kingdom, and Singapore. More information may be obtained at www.poet-technologies.com.This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward-looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee" or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include the Company's expectations with respect to the timely receipt of funds, completing the sale transaction of DenseLight, the success of the Company's product development efforts, the expected results of its operations, meeting revenue targets, and the expectation of continued success in the financing efforts, the capability, functionality, performance and cost of the Company's technology as well as the market acceptance, inclusion and timing of the Company's technology in current and future products.Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Assumptions have been made regarding, among other things, management's expectations regarding the success and timing for completion of its development efforts, financing activities, sale of its DenseLight subsidiary, future growth, plans for and completion of projects by the Company's third-party consultants, contractors and partners, availability of capital, and the necessity to incur capital and other expenditures. Actual results could differ materially due to a number of factors, including, without limitation, operational risks in the completion of the Company's anticipated projects, delays or changes in plans with respect the receipt of funds from third-parties, the closing of the sale of DenseLight, completion of the Company's anticipated projects by the Company's third-party suppliers, risks affecting the Company's ability to execute projects, the ability of the Company to generate sales for its products, the ability to attract key personnel, and the ability to raise additional capital, and its ability to complete all the agreements required for the sale of the subsidiary. Although the Company believes that the expectations reflected in the forward-looking information or statements are reasonable, prospective investors in the Company's securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise this forward-looking information and statements except as required by law.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 – Fax: 416-322-5075____________________________
1 See: https://www.wsj.com/articles/back-door-capital-outflows-should-worry-beijing-11571051723; https://chinadashboard.asiasociety.org/winter-2019/page/cross-border-investment; and https://chinachange.org/2018/11/08/signs-of-china-5-tightening-the-screws-on-chinas-foreign-reserves/, among others.
goeasy Ltd. Announces Enhancements to Credit Facility
Financial 15 Split Corp. Establishes At-The-Market Equity Program


text:
@class PDTableViewCell;

@protocol PDTableViewCellDelegate <NSObject>

- (void)cellDidBeginEdit:(PDTableViewCell*)cell;

@end

@interface PDTableViewCell : UITableViewCell <UITextFieldDelegate>

@property (nonatomic, weak) IBOutlet UILabel *titleLabel;
@property (nonatomic, weak) IBOutlet UILabel *valueLabel;
@property (nonatomic, weak) IBOutlet UILabel *errorLabel;
@property (nonatomic, weak) IBOutlet UITextField *textField;
@property (nonatomic, weak) IBOutlet UIImageView *iconImageView;
@property (nonatomic, weak) IBOutlet UIActivityIndicatorView *activityIndicator;
@property (nonatomic, strong) id <PDItemInfo> item;
@property (nonatomic, readwrite) PDItemModel *model;

@property (nonatomic, weak) id <PDTableViewCellDelegate> delegate;

+ (BOOL)dynamicHeight;
+ (CGFloat)defaultHeight;
- (void)updateUI;
- (void)valueChanged;

@end


Nose: Smells like a wood shop, but under that thick lumber lies layers of caramel, dark fruit, Jim Beam spice, molasses, toffee, toasted nut, under ripe citrus and a mild astringency.
Palate: Caramel and wood battle it out with cinnamon chiming in from the sideline. That nutty character from the nose shows up with some dark fruit and leather in tow. Milling about in the background is some vanilla, a bit of yeast and that same astringency from the nose.
Notes: When whiskey is aged some of the liquid in the barrels is lost to evaporation, this is called the Angel's Share, but some soaks into the wood and stays there. Beam has coined this the Devil's Cut; which is where the whiskey gets it name. So how does Jim Beam go about creating their Devil's Cut?First they take barrels of whiskey that have been aged for at least 6 years, so they say, and dump them for blending. They then take those barrels and us a proprietary process involving water, mechanical agitation and heat to basically "sweat" the barrels and extract the bourbon from the wood. Then they add the extract back into the previously dumped whiskey and bottle it as Devil's Cut.